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Background: 
Antinuclear antibody (ANA) testing plays important role in diagnosis of 
connective tissue diseases (CTDs). There are only few studies on assessing the 
disease activity and severity of CTD with the help of ANA testing.  
Aim:  
The aim is to study the incidence, clinical patterns of CTDs and the utility of 
ANA testing in clinical correlation, disease activity and prognosis. 
Methods: 
This is a cross-sectional study of case series done in a prospective manner. 20 
patients were recruited in the study during the period from February 2015 to 
March 2016. ANA titre was done by IIF and ELISA in TVMCH microbiology 
laboratory and ANA profile by Western blot technique. ANA profile was 
repeated after six months of initial testing. 
Results: 
All CTD cases (100%) showed good improvement symptomatically and 
clinically in response to treatment within two months irrespective of their ANA 
profile. In repeat ANA profile after six months, antinucleosome antibody 
positivity increased to 13 cases from 7 cases and the change in ANA profile 
with respect to antinucleosome antibody was statistically significant (P<0.05). 
 
Conclusion: 
The reason for the appearance of new positivity in repeat ANA profile, in 
remission period, is not clearly known due to lack of information in standard 
literature. Those patients with new positivity should be followed up regularly to 
monitor disease activity and systemic involvement. 
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